You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,868,103


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,868,103
Title:Metal oxide coating of water insoluble ingredients
Abstract: The invention relates to process for coating a solid, water-insoluble particulate matter, with a metal oxide comprising: (a) contacting the solid water-insoluble particulate matter with a cationic additive in an aqueous medium to obtain a dispersion of said particulate matter having a positive zeta potential; (b) coating the solid water-insoluble particulate matter by precipitation of a metal oxide salt onto the surface of the particulate matter, forming a metal oxide layer thereon; and (c) aging said coating layer. The invention further relates to coated particulate matter obtained by the process and to compositions comprising solid, water-insoluble particulate matter, coated by a metal oxide layer, the particulate matter being a dermatological active agent or a pesticide. The invention additionally relates to methods of treating a surface condition in a subject using compositions comprising solid, water insoluble dermatologically active agent, coated by a metal oxide layer.
Inventor(s): Toledano; Ofer (Kfar Saba, IL), Sertchook; Hanan (Gedera, IL), Loboda; Natalia (Jerusalem, IL), Bar-Simantov; Haim (Modiin, IL)
Assignee: SOL-GEL TECHNOLOGIES LTD. (Ness Ziona, IL)
Application Number:11/997,823
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Process; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,868,103

Introduction

United States Patent 9,868,103 is a significant intellectual property asset, and understanding its scope and claims is crucial for stakeholders in the pharmaceutical industry. This analysis will delve into the details of the patent, its claims, and the broader patent landscape it operates within.

Patent Overview

Patent Number and Title The patent in question is U.S. Patent 9,868,103. While the specific title is not provided in the sources, it is associated with pharmaceutical drugs, indicating its relevance to medical treatments and therapies.

Claims Analysis

Claim Structure

Patent claims are the most critical part of a patent application, as they define the scope of the invention. For U.S. Patent 9,868,103, the claims would typically be divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Types

  • Independent Claims: These claims define the broadest scope of the invention. For a pharmaceutical patent, this might include the active ingredient, its formulation, and the method of use.
  • Dependent Claims: These claims narrow down the invention by adding additional limitations. For example, they might specify particular dosages, administration routes, or patient populations.

Scope of the Invention

Active Ingredient and Formulation

The patent likely covers a specific active ingredient or a combination of ingredients, along with their formulation. This could include details on the chemical structure, synthesis methods, and any unique characteristics of the drug.

Method of Use

Claims may also cover the method of using the drug, including dosing regimens, treatment protocols, and specific indications. This is crucial for ensuring that the patent protects not just the drug itself but also how it is administered and for what conditions.

Patent Landscape

Prior Art and Novelty

To be patentable, the invention must be novel and non-obvious over the prior art. The patent landscape analysis would involve searching existing patents and publications to ensure that the claims of U.S. Patent 9,868,103 are distinct and innovative compared to what has been previously disclosed[4].

Competing Patents

Understanding the competitive landscape involves identifying other patents that may cover similar or overlapping technologies. This can be done using tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases such as those provided by the European Patent Office (EPO) and the World Intellectual Property Organization (WIPO)[4].

Patent Analytics and Claim Coverage

Claim Coverage Matrix

A Claim Coverage Matrix can be used to analyze which patents and claims are actively protecting the intellectual property related to U.S. Patent 9,868,103. This involves categorizing patents by claims and scope concepts to identify gaps or opportunities in the patent coverage[3].

Claim Charts

Interactive claim charts generated by tools like ClaimScape® can help in reviewing patent coverage with technical experts. These charts facilitate the identification of whether a particular scope concept is applicable to a target product or method, aiding in determining gaps in current coverage and highlighting future design opportunities[3].

Practical Applications and Real-World Impact

Clinical Use

The practical application of the patented drug would involve its use in clinical settings. Claims that specify the use of the drug in real-world applications, such as treating specific diseases or improving patient outcomes, are more likely to be considered patent-eligible. This aligns with the USPTO's guidance on integrating judicial exceptions into practical applications[1].

Economic and Market Impact

Understanding the economic and market impact of U.S. Patent 9,868,103 involves analyzing its potential to dominate the market, create barriers to entry for competitors, and influence pricing and availability of the drug.

Legal and Regulatory Considerations

Patent Eligibility

The patent eligibility of U.S. Patent 9,868,103 would be evaluated under the USPTO's subject matter eligibility criteria. This includes assessing whether the claims integrate abstract ideas into practical applications and whether they offer concrete technological improvements[1].

International Protection

The patent's protection extends beyond the U.S. borders if it has been filed and granted in other countries. International patent databases and services like PATENTSCOPE by WIPO can provide insights into the global patent landscape and the extent of international protection[4].

Key Takeaways

  • Claims Analysis: Understanding the structure and scope of the claims is essential for determining the patent's coverage and protection.
  • Patent Landscape: Analyzing the competitive landscape helps in identifying potential overlaps and gaps in patent coverage.
  • Practical Applications: Specifying real-world applications of the patented invention is crucial for demonstrating patent eligibility.
  • Legal and Regulatory: Ensuring compliance with USPTO guidelines and international regulations is vital for maintaining the patent's validity.

FAQs

Q: What is the significance of independent and dependent claims in a patent? A: Independent claims define the broadest scope of the invention, while dependent claims narrow down the invention by adding additional limitations.

Q: How does the USPTO evaluate the patent eligibility of AI-related inventions? A: The USPTO evaluates AI-related inventions by assessing whether the claims integrate judicial exceptions into practical applications and whether they offer concrete technological improvements[1].

Q: What tools can be used to analyze the patent landscape for a specific patent? A: Tools such as the USPTO's Patent Public Search, Global Dossier, and international patent databases like those provided by the EPO and WIPO can be used to analyze the patent landscape[4].

Q: Why is it important to specify real-world applications in patent claims? A: Specifying real-world applications helps in demonstrating that the abstract idea is transformed into a practical application, which is a key criterion for patent eligibility[1].

Q: How can patent analytics help in managing intellectual property? A: Patent analytics, through tools like Claim Coverage Matrix and Claim Charts, helps in identifying gaps or opportunities in patent coverage and in determining the value and applicability of patent claims[3].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. 2024 Guidance Update on Patent Subject Matter Eligibility - Federal Register
  3. Patent Analytics - Schwegman
  4. Search for patents - USPTO
  5. Pharmaceutical drugs covered by patent 9,868,103 - Drug Patent Watch

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,868,103

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp EPSOLAY benzoyl peroxide CREAM;TOPICAL 214510-001 Apr 22, 2022 RX Yes Yes 9,868,103 ⤷  Subscribe Y TOPICAL TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA IN ADULTS 18 YEARS OF AGE AND OLDER ⤷  Subscribe
Galderma Labs Lp TWYNEO benzoyl peroxide; tretinoin CREAM;TOPICAL 214902-001 Jul 26, 2021 RX Yes Yes 9,868,103 ⤷  Subscribe Y TOPICAL TREATMENT OF ACNE VULGARIS IN ADULTS AND PEDIATRIC PATIENTS 9 YEARS OF AGE AND OLDER ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,868,103

PCT Information
PCT FiledAugust 02, 2006PCT Application Number:PCT/IL2006/000892
PCT Publication Date:February 08, 2007PCT Publication Number: WO2007/015243

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.